A Study of Teropavimab and Zinlirvimab in Combination With Capsid Inhibitor Lenacapavir in Virologically Suppressed Adults With HIV-1 Infection

计划入组 83 人 · 首次发布于 2023 年 2 月 15 日

HIV Attachment Inhibitor to Treat Human Immunodeficiency Virus 1 (HIV-1) Infections

计划入组 254 人 · 首次发布于 2011 年 6 月 29 日

Pharmacodynamics, Safety and Pharmacokinetics of BMS-663068, an HIV Attachment Inhibitor, in HIV-1

计划入组 50 人 · 首次发布于 2009 年 11 月 9 日

HIV-1 p24 capsid protein inhibitors (Shandong University)

HIV capsid protein inhibitor (Hengrui Medicine)

HIV capsid assembly inhibitors(Boehringer Ingelheim)

Worcester HIV Vaccine

United States

NHI-1

United States

HIV VACCINE TRIALS NETWORK

United States

FDA Approves Sunlenca (Lenacapavir), a First-in-Class HIV-1 Capsid Inhibitor

FDA Accepts Gilead's Lenacapavir for HIV Prevention with Priority Review

Dr. Reddy's and Hetero Partner with Gilead to Produce Generic HIV Drug Lenacapavir